Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects

The Journal of Clinical Endocrinology and Metabolism
Hung PhamKaren L Jones

Abstract

It is not known whether glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels correlate within individuals, nor whether levels change with age. Previous studies have all been cross-sectional in design. To evaluate longitudinal changes in fasting and glucose-stimulated incretin hormone concentrations in healthy older subjects. Forty-one healthy older subjects had measurements of plasma GLP-1 and GIP while fasting and after a 75-g oral glucose load on two occasions separated by 5.9 ± 0.1 years [mean age at the initial study: 71.2 ± 3.8 (SD) years]. Breath samples were collected to calculate the gastric 50% emptying time (T50). For GLP-1, both fasting concentrations (P < 0.001) and area under the curve 0 to 120 minutes (P = 0.001) were decreased at followup. Fasting GIP was also lower (P = 0.03) at follow up, but there was no change in the area under the curve 0 to 120 minutes (P = 0.26). The gastric emptying T50 was slower at followup (P = 0.008). Neither the change in T50 nor the body mass index at the initial study was a determinant of the change in incretin responses. Between the two study days, fasting GIP (r = 0.72, P < 0.001) correlated well, but not fasting GLP-1 (r = 0.23, P = 0.18)...Continue Reading

References

May 1, 1997·Diabetes Research and Clinical Practice·J C ChanC S Cockram
Dec 2, 1998·Diabetologia·L RanganathV Marks
Jun 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·G S MeneillyR A Pederson
Aug 29, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J KorosiG S Meneilly
Oct 1, 1964·The Journal of Clinical Endocrinology and Metabolism·H ELRICKY ARAI
Apr 15, 2006·Digestive Diseases and Sciences·Diana GentilcoreKaren L Jones
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Jul 5, 2007·American Journal of Physiology. Endocrinology and Metabolism·Amelia N PilichiewiczChristine Feinle-Bisset
Apr 15, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lawrence A SzarkaAlan R Zinsmeister
Mar 3, 2009·Vitamins and Hormones·Christopher H S McIntoshSu-Jin Kim
Nov 7, 2009·The Journal of Clinical Endocrinology and Metabolism·Adam M DeaneMichael Horowitz
Jun 30, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·T EdholmP M Hellström
Nov 23, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J E StevensK L Jones
Nov 26, 2010·Endocrinology and Metabolism Clinics of North America·Jessica ChangMichael Horowitz
Jan 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Laurence G TrahairKaren L Jones
Apr 25, 2013·Diabetes Care·Chinmay S MaratheMichael Horowitz
Apr 22, 2010·Journal of Diabetes Investigation·Yutaka SeinoDaisuke Yabe
May 24, 2014·Metabolism: Clinical and Experimental·Bruno GelonezeMarcos Antonio Tambascia
Jul 15, 2015·The Journal of Clinical Endocrinology and Metabolism·Chinmay S MaratheKaren L Jones
Jul 22, 2015·Clinics in Geriatric Medicine·Stijn SoenenKaren L Jones
Sep 7, 2016·The Journal of Clinical Endocrinology and Metabolism·Tongzhi WuChristopher K Rayner
Sep 6, 2017·Endocrine Development·Jochen Seufert
Jan 25, 2018·Diabetes, Obesity & Metabolism·Michael A Nauck, Juris J Meier
Apr 20, 2018·The Journal of Clinical Endocrinology and Metabolism·José de Jesús Garduno-GarciaNicolas Musi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.